Genomic Signatures for Patients With Initially Unresectable Colorectal Liver Metastases

CompletedOBSERVATIONAL

Enrollment

286

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

December 1, 2018

Study Completion Date

December 1, 2023

Conditions

Genomic InstabilityPrognostic Cancer Model

All Listed Sponsors

lead

The First Affiliated Hospital with Nanjing Medical University

OTHER

NCT06477718 - Genomic Signatures for Patients With Initially Unresectable Colorectal Liver Metastases | Biotech Hunter | Biotech Hunter